BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu L, Zhang BX, Du X, Yu Z, Yang XG, Jiang YX. Evaluating the effectiveness of chemotherapy for thymic epithelial tumors using the CD-DST method. Thorac Cancer 2020;11:1160-9. [PMID: 32196982 DOI: 10.1111/1759-7714.13362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Deng L. Identification of Immune-Related Hub Genes in Thymoma: Defects in CD247 and Characteristics of Paraneoplastic Syndrome. Front Genet 2022;13:895587. [DOI: 10.3389/fgene.2022.895587] [Reference Citation Analysis]
2 Du X, Yu L, Li F, Yu Z, Yang XG, Jiang YX, Yu XT. Case Report: MDM4 Amplified in a Thymoma Patient With Autoimmune Enteropathy and Myocarditis. Front Endocrinol (Lausanne) 2021;12:661316. [PMID: 34054730 DOI: 10.3389/fendo.2021.661316] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Yu Z, Yu L, Yu T, Yang XG, Zhang BX, Du X. Surgical feasibility and long-term outcome of superior vena cava replacement for advanced thymoma in patients undergoing preoperative chemotherapy or chemoradiotherapy. Thorac Cancer 2021;12:1074-83. [PMID: 33569912 DOI: 10.1111/1759-7714.13872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang L, Yu L, Du X, Huo C. [Analysis of Gene Variation in Thymoma by Microarray]. Zhongguo Fei Ai Za Zhi 2020;23:1073-9. [PMID: 33357314 DOI: 10.3779/j.issn.1009-3419.2020.102.46] [Reference Citation Analysis]